Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (231-240 of 494) with videos related to

Pageof 50
Sort By:
Human Pathology|December 28, 2016
βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancerAndrea Hinsch, Aref Chaker, Christian Burdelski, et al.
BMC Cancer|March 3, 2019
Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancerCornelia Schroeder, Jan Grell, Claudia Hube-Magg, et al.
Carcinogenesis|September 23, 2015
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parametersNathaniel Melling, Erik Thomsen, Maria Christina Tsourlakis, et al.
International Journal of Cancer|September 19, 2015
Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancersChristoph Burdelski, Sandra Kleinhans, Martina Kluth, et al.
World Journal of Urology|April 19, 2020
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinomaTill Eichenauer, Luca Simmendinger, Christoph Fraune, et al.
BMC Cancer|December 7, 2011
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signalingJan C Brase, Marc Johannes, Heiko Mannsperger, et al.
Anticancer Research|April 30, 2014
MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotypeStefan Steurer, Ahmad Shoaib Seddiqi, Julius Magnus Singer, et al.
BMC Cancer|June 2, 2018
PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancerMarie-Christine Heinrich, Cosima Göbel, Martina Kluth, et al.
Oncotarget|April 1, 2015
HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomyCristina Villares Zabalza, Meike Adam, Christoph Burdelski, et al.
Experimental and Molecular Pathology|May 28, 2018
Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancerEmily Neubauer, Morwari Latif, Jenny Krause, et al.
Pageof 50

Showing results (231-240 of 494) with videos related to

Sort By:
Pageof 50
Human Pathology|December 28, 2016
βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancerAndrea Hinsch, Aref Chaker, Christian Burdelski, et al.
BMC Cancer|March 3, 2019
Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancerCornelia Schroeder, Jan Grell, Claudia Hube-Magg, et al.
Carcinogenesis|September 23, 2015
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parametersNathaniel Melling, Erik Thomsen, Maria Christina Tsourlakis, et al.
International Journal of Cancer|September 19, 2015
Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancersChristoph Burdelski, Sandra Kleinhans, Martina Kluth, et al.
World Journal of Urology|April 19, 2020
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinomaTill Eichenauer, Luca Simmendinger, Christoph Fraune, et al.
BMC Cancer|December 7, 2011
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signalingJan C Brase, Marc Johannes, Heiko Mannsperger, et al.
Anticancer Research|April 30, 2014
MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotypeStefan Steurer, Ahmad Shoaib Seddiqi, Julius Magnus Singer, et al.
BMC Cancer|June 2, 2018
PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancerMarie-Christine Heinrich, Cosima Göbel, Martina Kluth, et al.
Oncotarget|April 1, 2015
HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomyCristina Villares Zabalza, Meike Adam, Christoph Burdelski, et al.
Experimental and Molecular Pathology|May 28, 2018
Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancerEmily Neubauer, Morwari Latif, Jenny Krause, et al.
Pageof 50